Efficacy and Safety of 3 Different Dosage Regimens of Hyaluronic Acid in Patients With Knee Osteoarthritis (OA)

NCT01290497 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2014-03-03

No results posted yet for this study

Summary

The main objective is the comparison of three different dosage regimens of hyaluronic acid in the treatment of osteoarthritis of the knee.

Conditions

  • Osteoarthritis of the Knee

Interventions

DRUG

Hyaluronic acid 5 x 2.5 ml

5 intraarticular administration of Adant® 2.5ml with one week interval between administrations (standard treatment)

DRUG

Hyaluronic acid 1 x 5 ml

1 intraarticular administration of Adant® 5ml

DRUG

Hyaluronic acid 2 x 5 ml

2 intraarticular administration of Adant® 5ml with a two-week interval between administrations.

Sponsors & Collaborators

  • Tedec-Meiji Farma, S.A.

    lead INDUSTRY

Principal Investigators

  • Alejandro Escudero

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-10-31
Completion
2011-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01290497 on ClinicalTrials.gov